Difference between revisions of "Health Outcomes Measures"

From Patient Determinants
Jump to: navigation, search
 
Line 3: Line 3:
 
* [https://euroqol.org/eq-5d-instruments/ EQ-5D is a standardized instrument developed by the EuroQol Group] as a measure of health-related quality of life  
 
* [https://euroqol.org/eq-5d-instruments/ EQ-5D is a standardized instrument developed by the EuroQol Group] as a measure of health-related quality of life  
  
* [https://www.rand.org/health-care/surveys_tools/mos/12-item-short-form.html The 12-Item Short Form Health Survey (SF-12) was developed for the Medical Outcomes Study (MOS)], a multi-year study of patients with chronic conditions. Also [https://www.rand.org/health-care/surveys_tools/mos/20-item-short-form.html 20-Item Short Form Survey (SF-20)] & [https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html 36-Item Short Form Survey (SF-36)]
+
* [https://www.rand.org/health-care/surveys_tools/mos/12-item-short-form.html The 12-Item Short Form Health Survey (SF-12) was developed for the Medical Outcomes Study (MOS)], a multi-year study of patients with chronic conditions. Also [https://www.rand.org/health-care/surveys_tools/mos/20-item-short-form.html 20-Item Short Form Survey (SF-20)] & [https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html 36-Item Short Form Survey (SF-36)] [https://www.rand.org/health-care/surveys_tools.html See More Rand Healthcare Surveys]
  
 
* [https://www.fiercehealthcare.com/analytics/patient-generated-data-could-be-missing-piece-to-new-payment-models-for-drugs-and-devices A new consortium] aims to tackle the complex issue of value-based payment for drugs, medical devices and cutting-edge gene therapy. A major part of that initiative will be defining the role of patient provided data in new value-based arrangements.
 
* [https://www.fiercehealthcare.com/analytics/patient-generated-data-could-be-missing-piece-to-new-payment-models-for-drugs-and-devices A new consortium] aims to tackle the complex issue of value-based payment for drugs, medical devices and cutting-edge gene therapy. A major part of that initiative will be defining the role of patient provided data in new value-based arrangements.

Latest revision as of 15:53, 5 January 2019

Organizations Focused on developing Health Outcomes Measures

  • A new consortium aims to tackle the complex issue of value-based payment for drugs, medical devices and cutting-edge gene therapy. A major part of that initiative will be defining the role of patient provided data in new value-based arrangements.
  • International Consortium for Health Outcomes Measurement (ICHOM) is a non-profit organization who believe outcomes are the ultimate measure of success in health care. When seeking treatment, patients want to know what their life will be like after treatment: will I return to work, will I be able to take care of myself, and will my symptoms improve?